---
kind: "section"
citation: "34 U.S.C. § 10701"
title: "34"
title_heading: "Crime Control and Law Enforcement"
number: "10701"
heading: "Description"
release: "119-102"
date: "2026-07-12"
url: "https://uscodex.org/usc/34/10701"
units:
  - "Subtitle I — Comprehensive Acts"
  - "Chapter 101 — Justice System Improvement"
  - "Subchapter XXXVIII — Comprehensive Opioid Abuse Grant Program"
---

# §10701. Description

- (a) **Grants authorized—** From amounts made available to carry out this subchapter, the [Attorney General](/usc/34/10307.md?p=1) may make grants to [States](/usc/34/11103.md?p=7), units of local government, and [Indian tribes](/usc/34/11103.md?p=18), for use by the [State](/usc/34/11103.md?p=7), [unit of local government](/usc/34/11103.md?p=8), or [Indian tribe](/usc/34/11103.md?p=18) to provide [services](/usc/34/12291.md?p=a-51) primarily relating to [opioid](/usc/34/10705.md?p=3) abuse, including for any one or more of the following:
  - (1) Developing, implementing, or expanding a [treatment](/usc/34/11103.md?p=15) alternative to incarceration program, which may include—
    - (A) prebooking or postbooking components, which may include the activities described in subchapter XXIX or XXXIII of this chapter;
    - (B) training for [criminal justice agency](/usc/34/10705.md?p=6) personnel on substance use disorders and co-occurring mental illness and substance use disorders;
    - (C) a mental health court, including the activities described in subchapter XXI of this chapter;
    - (D) a [drug](/usc/34/10705.md?p=5) court, including the activities described in subchapter XXX of this chapter;
    - (E) a veterans [treatment](/usc/34/11103.md?p=15) court program, including the activities described in subsection (i) of [section 10651 of this title](/usc/34/10651.md);
    - (F) a focus on parents whose incarceration could result in their children entering the child welfare system;
    - (G) a community-based substance use diversion program sponsored by a [law enforcement](/usc/34/12291.md?p=a-23) agency; and
    - (H) a pilot program for [rural areas](/usc/34/12291.md?p=a-32) to implement community response programs that focus on reducing [opioid](/usc/34/10705.md?p=3) overdose deaths, which may include presenting alternatives to incarceration, as described in [subsection (f)](#f).
  - (2) In the case of a [State](/usc/34/11103.md?p=7), facilitating or enhancing planning and collaboration between [State](/usc/34/11103.md?p=7) [criminal justice agencies](/usc/34/10705.md?p=6) and [State substance abuse agencies](/usc/34/10705.md?p=8) in order to more efficiently and effectively carry out activities or [services](/usc/34/12291.md?p=a-51) described in any paragraph of this subsection that address problems related to [opioid](/usc/34/10705.md?p=3) abuse.
  - (3) Providing training and resources for [first responders](/usc/34/10705.md?p=1) on carrying and administering an [opioid](/usc/34/10705.md?p=3) overdose reversal [drug](/usc/34/10705.md?p=5) or [device](/usc/34/10705.md?p=5) approved or cleared by the Food and [Drug](/usc/34/10705.md?p=5) Administration, and purchasing such a [drug](/usc/34/10705.md?p=5) or [device](/usc/34/10705.md?p=5) for [first responders](/usc/34/10705.md?p=1) who have received such training to so carry and administer.
  - (4) Locating or investigating illicit activities related to the unlawful distribution of [opioids](/usc/34/10705.md?p=3).
  - (5) Developing, implementing, or expanding a [medication-assisted treatment](/usc/34/10705.md?p=2) program used or operated by a [criminal justice agency](/usc/34/10705.md?p=6), which may include training [criminal justice agency](/usc/34/10705.md?p=6) personnel on [medication-assisted treatment](/usc/34/10705.md?p=2), and carrying out the activities described in subchapter XVIII of this chapter.
  - (6) In the case of a [State](/usc/34/11103.md?p=7), developing, implementing, or expanding a prescription [drug](/usc/34/10705.md?p=5) monitoring program to collect and analyze data related to the prescribing of schedules II, III, and IV controlled substances through a centralized database administered by an authorized [State](/usc/34/11103.md?p=7) agency, which includes tracking the dispensation of such substances, and providing for interoperability and data sharing with each other such program in each other [State](/usc/34/11103.md?p=7), and with any interstate entity that shares information between such programs.
  - (7) Developing, implementing, or expanding a program to prevent and address [opioid](/usc/34/10705.md?p=3) abuse by juveniles.
  - (8) Developing, implementing, or expanding a program (which may include demonstration projects) to utilize technology that provides a secure container for prescription [drugs](/usc/34/10705.md?p=5) that would prevent or deter individuals, particularly adolescents, from gaining access to [opioid](/usc/34/10705.md?p=3) medications that are lawfully prescribed for other individuals.
  - (9) Developing, implementing, or expanding a prescription [drug](/usc/34/10705.md?p=5) take-back program.
  - (10) Developing, implementing, or expanding an integrated and comprehensive [opioid](/usc/34/10705.md?p=3) abuse response program.
- (b) **Contracts and subawards—** A [State](/usc/34/11103.md?p=7), [unit of local government](/usc/34/11103.md?p=8), or [Indian tribe](/usc/34/11103.md?p=18) may, in using a grant under this subchapter for purposes authorized by [subsection (a)](#a), use all or a portion of that grant to contract with, or make one or more subawards to, one or more—
  - (1) local or regional organizations that are private and nonprofit, including faith-based organizations;
  - (2) units of local government; or
  - (3) [tribal organizations](/usc/34/10705.md?p=7).
- (c) **Program assessment component; waiver—**
  - (1) **Program assessment component—** Each program funded under this subchapter shall contain a program [assessment](/usc/34/11103.md?p=38) component, developed pursuant to guidelines established by the [Attorney General](/usc/34/10307.md?p=1), in coordination with the [National Institute of Justice](/usc/34/11103.md?p=4-C).
  - (2) **Waiver—** The [Attorney General](/usc/34/10307.md?p=1) may waive the requirement of [paragraph (1)](#c-1) with respect to a program if, in the opinion of the [Attorney General](/usc/34/10307.md?p=1), the program is not of sufficient size to justify a full program [assessment](/usc/34/11103.md?p=38).
- (d) **Administrative costs—** Not more than 10 percent of a grant made under this subchapter may be used for costs incurred to administer such grant.
- (e) **Period—** The period of a grant made under this subchapter may not be longer than 4 years, except that renewals and extensions beyond that period may be granted at the discretion of the [Attorney General](/usc/34/10307.md?p=1).
- (f) **Rural pilot program—**
  - (1) **In general—** The pilot program described under this subsection shall make grants to [rural areas](/usc/34/12291.md?p=a-32) to implement community response programs to reduce [opioid](/usc/34/10705.md?p=3) overdose deaths. Grants issued under this subsection shall be jointly operated by units of local government, in collaboration with public safety and public health agencies or public safety, public health and behavioral health collaborations. A community response program under this subsection shall identify gaps in community prevention, [treatment](/usc/34/11103.md?p=15), and recovery [services](/usc/34/12291.md?p=a-51) for individuals who encounter the criminal justice system and shall establish [treatment](/usc/34/11103.md?p=15) protocols to address identified shortcomings. The [Attorney General](/usc/34/10307.md?p=1), through the [Office of Justice Programs](/usc/34/11103.md?p=4-B), shall increase the amount provided as a grant under this section for a pilot program by no more than five percent for each of the two years following certification by the [Attorney General](/usc/34/10307.md?p=1) of the submission of data by the [rural area](/usc/34/12291.md?p=a-32) on the prescribing of schedules II, III, and IV controlled substances to a prescription [drug](/usc/34/10705.md?p=5) monitoring program, or any other centralized database administered by an authorized [State](/usc/34/11103.md?p=7) agency, which includes tracking the dispensation of such substances, and providing for interoperability and data sharing with each other such program (including an electronic health records system) in each other [State](/usc/34/11103.md?p=7), and with any interstate entity that shares information between such programs.
  - (2) **Rules of construction—** Nothing in this subsection shall be construed to—
    - (A) direct or encourage a [State](/usc/34/11103.md?p=7) to use a specific interstate data sharing program; or
    - (B) limit or prohibit the discretion of a prescription [drug](/usc/34/10705.md?p=5) monitoring program for interoperability connections to other programs (including electronic health records systems, hospital systems, pharmacy dispensing systems, or health information exchanges).

## Source credit

(Pub. L. 90–351, title I, § 3021, as added Pub. L. 114–198, title II, § 201(a)(1), July 22, 2016, 130 Stat. 711; amended Pub. L. 117–250, § 2, Dec. 20, 2022, 136 Stat. 2352.)

## Notes

### Editorial Notes

### Codification

Section was formerly classified to section 3797ff of Title 42, The Public Health and Welfare, prior to editorial reclassification and renumbering as this section.

### Amendments

2022—Subsec. (a)(1)(H). Pub. L. 117–250, § 2(1), added subpar. (H).

Subsec. (f). Pub. L. 117–250, § 2(2), added subsec. (f).